Share on

Global HbA1c Testing Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Technology, End User and Region - Industry Size, Share, Growth, Trends, Forecast (2023 to 2028)

Published: March, 2023
ID: 5134
Pages: 175
Formats: report pdf report excel report power bi report ppt

HbA1c Testing Market Size (2023 to 2028)

The Global HbA1c Testing Market size is anticipated to grow at 11% CAGR from 2023 to 2028. It is estimated that the global market was valued at USD 1.8 billion in 2023 and is expected to reach USD 3.04 billion by 2028.

HbA1c is a modified form of an oxygen-carrying pigment in red blood cells called hemoglobin. Most hemoglobin is in HbA form, but a small fraction transforms into HbA1 during their lifespans. In further findings, scientists discovered in the 1950s that HbA1 could further be separated into HbA1a, HbA1b, and HbA1c. Patients with diabetes have an alarmingly high level of HbA1c in their bodies as its formation occurs only during a process called glycosylation, which involves converting glucose into glycogen for storage purposes.


The growing incidence of diabetes is one of the key factors propelling the HbA1c testing market.

The number of people affected by diabetes increases exponentially daily due to poor dietary choices, lack of physical activities, and high-stress levels. As a result, physicians are increasingly prescribing HbA1c tests to their patients, which is expected to drive the market revenue for HbA1c Testing. Moreover, the emergence of point of care and other new devices to lower the cost of diabetes testing is further expected to aid the HbA1c Testing Market growth.

The senior population is increasing continually, leading to a rise in diabetic patients' accounts worldwide. Innovative testing procedures and handheld devices due to technological advancements are expected to provide lucrative opportunities for the HbA1c testing market stakeholders. The increased scope of medical tourism in developing countries is likely to boost the HbA1c testing market opportunities. Growing awareness among people to manage diabetes efficiently is expected to offer growth opportunities for the key players in the market.

Increasing demand for handheld analyzers and proliferated diagnostic laboratories in remote locations of countries like India and China are expected to provide lucrative growth opportunities for the HbA1c market during the forecast period. In addition, the rise in the affordability of testing devices in hospitals due to patient footfalls will likely provide more opportunities for the HbA1c testing market's growth during the forecast period. Prevalence for early disease diagnosis among people also lavishes the market's growth. 


The devices used for testing are costly. The adoption of these technologies is minimal in developing countries, which is expected to limit the growth of the HbA1c testing market. Manufacturing costs of these devices are high resulting in limited production of HbA1c testing devices, posing a challenge to the key players in the HbA1c market. Another major challenge is inaccuracies in the testing due to discrepancies in interpretations expected to resist the market's growth during the forecast period. Stringent rules and regulations by the government may also negatively impact the HbA1c Testing Market's growth rate. 

Impact of COVID-19 on the global HbA1c market:

The COVID-19 pandemic has brought the world to a standstill affecting millions of people. The pandemic crisis has impacted diabetic people. In March and April 2020, HbA1c testing volume decreased by 66%. Decrements in HbA1c test volumes convert to postponed testing. A decline in HbA1c testing frequency relevant to the COVID-19 pandemic is likely to reflect more prominent clinical care disturbances based on stay-at-home orders and social distancing. The intentions mentioned above were deprived of people with various reasons for missing testing over the pandemic. The analysis suggests that missed HbA1c testing during the pandemic led to significant adverse impacts on glucose control, clinical outcomes, and diabetes-related medical prices.




Market Size Available

2022 to 2028

Base Year


Forecast Period

2023 to 2028

Segments Covered

By Technology, Type, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa


This research report on the global HbA1c testing market has been segmented and sub-segmented based on the technology, type, end-user, and region.

HbA1c Testing Market – By Technology:

  • Ion-Exchange HPCL             
  • Enzymatic Assay   
  • Affinity Binding Chromatography  
  • Turbidimetric Inhibition Immunoassay       
  • Other       

Based on technology, the affinity binding chromatography segment held the largest share in the HbA1c testing market in 2022, owing to the increasing investments and support. 

The Ion-Exchange HPCL segment is another lucrative segment in the global HbA1C market. Due to the various advantages over other technologies, Ion exchange is most widely used for HbA1c testing. The HPLC consumes less time, recognizes variants, and is utilized in Point-of-care settings.  

The Turbidimetric inhibition immunoassay is anticipated to grow healthy during the forecast period. The segment provides accurate results; it is cost-effective and quick swiftness. 

HbA1c Testing Market – By Type:

  • Hand-Held Devices               
  • Bench Top Devices         

Based on type, in 2021, benchtop devices led the market segment due to their fast and accurate results.  

HbA1c Testing Market – By End User:

  • Hospital    
  • Home Care              
  • Diagnostic laboratory          
  • Research Institution            

Based on end-user, the homecare segment is projected to account for most of the market share during the forecast period due to the rising popularity of home care services, a crucial factor governing this segment's growth. Furthermore, escalating preference for diabetic patients regarding self-monitoring HbA1clevels and the capability of the tests to provide quick outputs favors the segment to excel more.

HbA1c Testing Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

As of 2022, North America accounted for the largest share of the HbA1c Testing market, followed by Europe and the Asia Pacific. However, the Asia Pacific is projected to register the highest growth rate in the coming years due to diabetes's growing cases of diabetes. Moreover, low healthcare costs are crucial in boosting medical tourism in the region, which will aid market growth.


The promising companies leading the Global HbA1c Testing Market profiled in this report are Transasia Biomedicals Ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and Trinity Biotech plc.


  • Bio-Rad Laboratories Inc. conducted a D-10 HbA1c program for identifying and diagnosing diabetic patients. The FDA approved this program in July 2017. With this approval, the adoption rate of D-10 HbA1c testing systems has been escalated due to their ability to diagnose diabetic patients.
  • Seimens healthiness developed Atellica CH Enzymatic HbA1c Assay for monitoring and diagnosing diabetes. The FDA approved it, and the product was launched in May 2019. These instruments are implemented in laboratories to acquire higher efficiency and productivity by conducting tests on more significant volumes.

Please wait. . . . Your request is being processed


How much was the global HbA1c testing market worth in 2021?

The global HbA1c testing market was valued at USD 1.47 billion in 2021.

Which region held the major share in the global HbA1c testing market in 2021?

The North American region was the market leader in the global market in 2021.

Which segment by technology led the HbA1c testing market in 2021?

Based on the technology, the affinity binding chromatography segment dominated the market in 2021. 

Who are some of the notable players in the HbA1c testing market?

Transasia Biomedicals Ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and Trinity Biotech plc are some of the noteworthy companies in the HbA1c testing market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]